Judge it!
This agent has orphan drug status via the FDA as well as Fast Track Designation in a number of solid tumors, so it is probably not without some credibility.
I wonder why on earth is there nothing in the prostate cancer literature or web sites about it?
Oct 13, 2009 | Posted by: roboblogger
Clinical Remissions In Three Otherwise Intractable Cancers Signal The ...
Epeius Biotechnologies Corporation announced more stunning results of its pioneering clinical studies of Rexin-G, the world's first and, so far only, tumor-targeted genetic medicine to be validated in the clinic.
Comments
Showing posts
1 - 1 of1
|
|
||||
|
||||
Showing posts
1 - 1 of1
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
Other Recent Oncology Discussions
Search the Oncology Forum:
Search the Oncology Forum:
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| New cancer policy causes concern | 7 hr | Thanks BCBS | 13 |
| Drug policy criticized | 13 hr | FJX | 13 |
| Cellular Origins Of Tasmanian Devil Facial Tumo... | 15 hr | Stephany McD... | 2 |
| Insurance company policy on cancer drugs draws ... | 15 hr | Old Crafter | 2 |
| Sophisticated new equipment for cancer treatmen... | Sun | JJJ | 8 |
| Chicago New Year's Eve Party With Joe Piscopo a... | Dec 31 | flockewe | 1 |
| Angel of comfort - Hawaii News | Dec 30 | Sandy Platt | 6 |
Daily Horoscope for January 5
Aries
There is minor evil around today, whether it is harsh words or actions. Relationships with non spiritual people will tend to be abrasive, as you come to understand that such people can never be trusted, for their agenda is not love. Beware of criticism from colleagues or friends. Avoid being narrow minded and confining your views to the conventional. You may want to argue with everyone and everything, but beware of devouring your own energy in the process.
|
Reach local customers. Engage a specific demographic. Maximize business-to-business opportunities. Topix can deliver your message.
|
Copyright ©2009 Topix LLC
